Valuation : Kamada Ltd.

Market Cap 1.41B 141B 464M 400M 377M 343M 641M 44.3B 648M 4.49B 1.73B 22.53B 1.74B 1.71B 71.67B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 1.41B 141B 464M 400M 377M 343M 641M 44.3B 648M 4.49B 1.73B 22.53B 1.74B 1.71B 71.67B EV / Sales 2026 *
2.33x
EV / Sales 2027 * 2.1x
Free-Float
54.48%
Yield 2026 *
-
Yield 2027 * -
1 day-1.53%
1 week-3.35%
Current month+0.08%
1 month+14.47%
3 months+14.26%
6 months-9.49%
Current year+8.50%
1 week 2,443
Extreme 2443
2,546
1 month 2,013
Extreme 2013
2,578
Current year 2,013
Extreme 2013
2,890
1 year 1,956
Extreme 1956
2,890
3 years 1,685
Extreme 1685
3,045
5 years 1,309
Extreme 1309
3,045
10 years 1,309
Extreme 1309
4,500
Manager TitleAgeSince
Chief Executive Officer 58 01/07/2015
Director of Finance/CFO 56 31/12/2017
Chief Operating Officer 54 01/11/2016
Director TitleAgeSince
Director/Board Member 75 13/12/1990
Chairman 77 07/03/2013
Chairman 55 12/08/2020
Date Insider Type Main position Quantity % Market Cap. Importance
02/09/26 Exercice

VP Quality

6,937 0.0120%
02/09/26 Exercice

Founder

107,166 0.1857%
26/08/26 Exercice

VP Quality

68,328 0.1184%
Change 5-day change 1-year change 3-year change Capi.($)
-1.53%-3.35%+1.74%+19.03% 474M
-1.78%-6.90%+42.54%-4.51% 80.65B
-1.00%-2.50%-19.26%-37.42% 59.12B
+0.74%-9.41%+458.32%+26.92% 54.14B
-2.00%-5.20%-11.09%+27.83% 50.1B
-1.42%-8.53%-3.54%+144.43% 45.33B
+2.23%-3.25%+50.02%-16.82% 31.14B
-2.17%-4.31%+44.02%+92.69% 25.54B
-3.92%-7.32%-6.49%+166.90% 21.8B
-0.99%-3.56%+58.64%+102.21% 16.06B
Average -1.31%-3.59%+61.49%+52.13% 38.44B
Weighted average by Cap. -1.25%-3.84%+77.72%+36.31%

Financials

2026 *2027 *
Net sales 606M 60.59B 199M 171M 161M 147M 274M 18.98B 278M 1.92B 740M 9.65B 747M 730M 30.7B 673M 67.32B 221M 190M 179M 163M 305M 21.09B 308M 2.14B 823M 10.72B 830M 812M 34.11B
Net income 84.8M 8.48B 27.83M 23.99M 22.6M 20.54M 38.41M 2.66B 38.85M 269M 104M 1.35B 105M 102M 4.3B 104M 10.41B 34.17M 29.46M 27.75M 25.22M 47.16M 3.26B 47.7M 330M 127M 1.66B 128M 126M 5.28B
Net Debt - -
Logo Kamada Ltd.
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Employees
462
Date Price Change Volume
10/09/26 ILA 2,452.00 -1.53% 69,336
09/09/26 ILA 2,490.00 +0.08% 130,011
08/09/26 ILA 2,488.00 -0.12% 317,225
07/09/26 ILA 2,491.00 0.00% 57,863
04/09/26 ILA 2,491.00 +0.44% 90,400
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KMDA Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!